Cordis SELUTION SLR 3.0 x 35 mm sirolimus-eluting PTCA balloon catheter (REF SC14-300035) designed for controlled, sustained sirolimus delivery to the coronary vessel wall during percutaneous coronary intervention.
Cordis SELUTION SLR Sirolimus Eluting PTCA Balloon Catheter, 3.0 x 40 mm (REF SC14-300040) - a drug-coated balloon designed for coronary intervention using MicroReservoir sirolimus-release technology.
Cordis SELUTION SLR Sirolimus Eluting PTCA Balloon Catheter, 3.25 mm x 10 mm (REF SC14-325010), a drug-eluting balloon engineered for controlled, sustained sirolimus delivery during percutaneous coronary intervention.
Cordis SELUTION SLR sirolimus-eluting PTCA balloon catheter, 3.25 mm x 15 mm (REF SC14-325015), designed for controlled sirolimus delivery during percutaneous coronary intervention.
Cordis SELUTION SLR Sirolimus Eluting PTCA Balloon Catheter, 3.25 mm x 20 mm (REF SC14-325020) - drug-coated coronary balloon delivering sirolimus via MicroReservoir technology for percutaneous coronary interventions.
Cordis SELUTION SLR Sirolimus Eluting PTCA Balloon Catheter, 3.25 mm x 25 mm (REF SC14-325025) - a sustained-release sirolimus drug-coated balloon designed for percutaneous transluminal coronary angioplasty procedures.
Cordis SELUTION SLR Sirolimus Eluting PTCA Balloon Catheter, 3.25 mm x 30 mm (REF SC14-325030) - sirolimus drug-coated balloon designed for percutaneous transluminal coronary angioplasty with sustained limus release technology.
Cordis SELUTION SLR Sirolimus Eluting PTCA Balloon Catheter, 3.25 mm diameter x 35 mm length (REF SC14-325035), a drug-coated balloon engineered for controlled sirolimus delivery during percutaneous coronary intervention.
Cordis SELUTION SLR Sirolimus Eluting PTCA Balloon Catheter, 3.25 mm x 40 mm, REF SC14-325040, designed for controlled, sustained sirolimus delivery during percutaneous coronary intervention.
Cordis SELUTION SLR sirolimus-eluting PTCA balloon catheter, 3.5 mm x 10 mm (REF SC14-350010) for coronary intervention.
Cordis SELUTION SLR sirolimus-eluting PTCA balloon catheter, 3.5 mm x 15 mm (REF SC14-350015), designed for controlled sirolimus delivery to the coronary vessel wall during percutaneous coronary intervention.
Cordis SELUTION SLR sirolimus-eluting PTCA balloon catheter, 3.5 mm x 20 mm (REF SC14-350020), designed for controlled sirolimus delivery during percutaneous coronary intervention.
Cordis SELUTION SLR 3.5 x 25 mm sirolimus-eluting PTCA balloon catheter (REF SC14-350025) for coronary intervention, featuring MicroReservoir sustained-release sirolimus technology on a rapid-exchange balloon platform.
Cordis SELUTION SLR 3.5 x 30 mm sirolimus-eluting PTCA balloon catheter (REF SC14-350030) for percutaneous coronary intervention, featuring MicroReservoir sustained sirolimus release technology.
Cordis SELUTION SLR Sirolimus Eluting PTCA Balloon Catheter, 3.5 mm x 35 mm (REF SC14-350035) - a drug-eluting balloon designed for percutaneous transluminal coronary angioplasty using a sustained sirolimus release technology.
Cordis SELUTION SLR 3.5 x 40 mm sirolimus-eluting PTCA balloon catheter (REF SC14-350040) for controlled, sustained sirolimus delivery during percutaneous coronary intervention.
Cordis SELUTION SLR Sirolimus Eluting PTCA Balloon Catheter, 3.75 mm x 10 mm (REF SC14-375010) - a sirolimus-coated coronary balloon designed for percutaneous transluminal coronary angioplasty with sustained limus drug delivery via MicroReservoir technology.
Cordis SELUTION SLR Sirolimus Eluting PTCA Balloon Catheter, 3.75 mm x 15 mm (REF SC14-375015), a drug-eluting balloon engineered for controlled, sustained sirolimus release during coronary angioplasty procedures.
Cordis SELUTION SLR Sirolimus Eluting PTCA Balloon Catheter, 3.75 mm x 20 mm (REF SC14-375020) - a drug-coated coronary balloon delivering sirolimus via MicroReservoir technology for percutaneous coronary intervention.
Cordis SELUTION SLR Sirolimus Eluting PTCA Balloon Catheter, 3.75 mm x 25 mm (REF SC14-375025), a drug-coated balloon designed for percutaneous transluminal coronary angioplasty with sustained sirolimus release via MicroReservoir technology.
